The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

✍ Scribed by Ohyashiki, K; Aota, Y; Akahane, D; Gotoh, A; Miyazawa, K; Kimura, Y; Ohyashiki, J H

• Book ID: 110056510
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 109 KB
• Volume: 19
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2403989